Analgesia After Cesarean Section

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01360060

Enrollment

503

Registered

2011-05-25

Start date

2010-12-31

Completion date

2011-03-31

Last updated

2011-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia, Pregnancy

Brief summary

Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of magnesium in parturients undergoing Cesarean section.

Interventions

DRUGMagnesium Sulphate

Magnesium sulphate was infused for the management of preeclampsia at perioperative period.

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 50 Years

Healthy volunteers

Inclusion criteria

* parturients undergoing Cesarean section

Design outcomes

Primary

Measure	Time frame
Change of numeric rating scale (NRS) of postoperative pain during postoperative period	postoperative 1, 2, 3, and 4 day

Secondary

Measure	Time frame
incidence of stopping of intravenous PCA during postoperative 4 days	during postoperative 4 days
serum magnesium level of group P	preoperative 1 h and postoperative 1 day

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026